Paris, France

Christophe Philippo

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 5.0

ph-index = 4

Forward Citations = 93(Granted Patents)


Location History:

  • Reuil Malmaison, FR (2002)
  • Rueil Malmaison, FR (2000 - 2010)
  • Rueil, FR (2010)
  • Antony, FR (2011)
  • Paris, FR (2012 - 2013)
  • Gif sur Yvette, FR (2013)

Company Filing History:


Years Active: 2000-2013

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Christophe Philippo

Introduction

Christophe Philippo is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, holding a total of 13 patents. His work primarily focuses on the development of therapeutic compounds that have the potential to improve health outcomes.

Latest Patents

Among his latest patents are the "Thiadiazole and oxadiazole derivatives, preparation thereof and therapeutic use thereof." This invention relates to compounds that can exist in various states, including base or acid addition salts, and outlines methods for their preparation and therapeutic applications. Another significant patent is for "Substituted adamantanes and their therapeutic application," which involves tetrahydroquinoxaline urea derivatives and their preparation for therapeutic use.

Career Highlights

Christophe Philippo has worked with prominent companies in the pharmaceutical industry, including Sanofi-Aventis and Sanofi-Synthelabo. His experience in these organizations has allowed him to contribute to the development of innovative therapeutic solutions.

Collaborations

Throughout his career, Christophe has collaborated with esteemed colleagues such as Alain Jean Braun and Claudie Namane. These partnerships have further enriched his work and expanded the impact of his inventions.

Conclusion

Christophe Philippo's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…